Curative Biotechnology released its earnings results on May 25, 2021. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.

Q: Is Curative Biotechnology overvalued?

According to Wall Street analysts Curative Biotechnology’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Curative Biotechnology have?

Curative Biotechnology has 903,263,370 shares outstanding.

Q: What happened to Curative Biotechnology’s price movement after its last earnings report?

Curative Biotechnology reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.

16 Followers

CUBT Stock Chart & Stats

Advanced Chart >

Day’s Range― - ―

52-Week Range<$0.01 - $0.04

Previous CloseN/A

Volume185.23K

Average Volume (3M)201.06K

Market Cap

$11.83M

Enterprise ValueN/A

Total Cash (Recent Filing)$0.00

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.80

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding903,263,370

10 Day Avg. Volume64,103

30 Day Avg. Volume201,060

Standard Deviation3.09

R-Squared0.11

Alpha0.66

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)-19.40

P/FCF Ratio25.90

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Financials

Annual

Income Statement >

CUBT FAQ

What was Curative Biotechnology’s price range in the past 12 months?

Curative Biotechnology lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.

What is Curative Biotechnology’s market cap?

Curative Biotechnology’s market cap is $11.83M.

When is Curative Biotechnology’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Curative Biotechnology’s earnings last quarter?

Curative Biotechnology released its earnings results on May 25, 2021. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.

Is Curative Biotechnology overvalued?

According to Wall Street analysts Curative Biotechnology’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Curative Biotechnology pay dividends?

Curative Biotechnology does not currently pay dividends.

What is Curative Biotechnology’s EPS estimate?

Curative Biotechnology’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Curative Biotechnology have?

Curative Biotechnology has 903,263,370 shares outstanding.

What happened to Curative Biotechnology’s price movement after its last earnings report?

Curative Biotechnology reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Curative Biotechnology?

Currently, no hedge funds are holding shares in CUBT

---

Company Description

Curative Biotechnology

Connectyx Technologies Holdings Group, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Stuart, FL.

---